1. Additive predictive power of the CHA2DS2-VASc and HAS-BLED scores for mortality in patients with atrial fibrillation. (25th November 2020) Authors: Morrone, D; Kroep, S; Ricci, F; Renda, G; Patti, G; Kirchhof, P; Chuang, L.C; Van Hout, B; De Caterina, R Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Age-adjusted risk factors are independently associated with an increased risk of major bleeding during the two-year follow-up of the ETNA-AF-Europe registry. (14th October 2021) Authors: Kirchhof, P; De Groot, J.R; Weiss, T.W; Kelly, P; Monteiro, P; Deharo, J.C; De Asmundis, C; Lopez-De-Sa, E; Waltenberger, J; Steffel, J; Levy, P; Bakhai, A; Pecen, L; De Caterina, R Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Association between personalized evidence-based anticoagulation therapy and outcomes at 1-year follow-up in patients with atrial fibrillation: an analysis from the Atrial Fibrillation registry. (14th October 2021) Authors: Pokushalov, E; Losik, D; Kozlova, S; Konradi, A; Sekacheva, M; Ponomarenko, A; Krivosheev, Y; Mikheenko, I; Kretov, E; Steinberg, J.S Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cancer incidence during follow-up in patients with new-onset atrial fibrillation treated with DOACs and its impact on bleeding risk. (14th October 2021) Authors: Angeli, F; Bartoli, L; Fabrizio, M; Bergamaschi, L; Magnani, I; Paolisso, P; Armillotta, M; Sansonetti, A; Chiti, C; Stefanizzi, A; Toniolo, S; Foa, A; Rinaldi, A; Galie, N; Pizzi, C Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Characterization of long-term oral anticoagulant adherence trajectories among patients with atrial fibrillation: a retrospective observational study. (14th October 2021) Authors: Salmasi, S; Safari, A; De Vera, M; Lynd, L; Koehoorn, M; Barry, A.R; Andrade, J.G; Deyell, M.W; Rush, K; Zhao, Y; Loewen, P Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical features, management and outcomes of gastrointestinal bleeding in patients treated with oral anticoagulants. (14th October 2021) Authors: Marti Sanchez, D; Biscotti Rodil, B; Delgado Calva, F; Duarte Torres, J; Marschall, A; Dejuan Bitria, C; Rueda Linares, A; Rodriguez Torres, D; Del Castillo Carnevali, H; Alvarez Anton, S Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical implications of assessment of apixaban levels in elderly atrial fibrillation patients: J-ELD AF Registry sub-cohort analysis. (25th November 2020) Authors: Suzuki, S; Yamashita, T; Akao, M; Okumura, K Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Comparative adherence between DOAC and VKA in patients with atrial fibrillation: a 23-year retrospective observational study in Canada. (14th October 2021) Authors: Salmasi, S; Safari, A; De Vera, M.A; Lynd, L; Koehoorn, M; Bary, A.R; Andrade, J.G; Deyell, M; Rush, K; Zhao, Y; Loewen, P Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Comparative effectiveness of NOAC vs VKA in patients representing common clinical challenges: results from the GARFIELD-AF registry. (14th October 2021) Authors: Virdone, S; Himmelreich, J.C.L; Pieper, K.S; Camm, A.J; Bassand, J.-P; Fox, K.A.A; Fitzmaurice, D.A; Goldhaber, S.Z; Goto, S; Haas, S; Kayani, G; Misselwitz, F; Turpie, A.G.G; Verheugt, F.W.A; Kakkar, A.K Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Comparing rivaroxaban and apixaban in GARFIELD-AF according to ROCKET AF and ARISTOTLE trial selection criteria. (14th October 2021) Authors: Himmelreich, J.C.L; Virdone, S; Camm, A.J; Harskamp, R.E; Pieper, K.S; Fox, K.A.A; Bassand, J.-P; Fitzmaurice, D.A; Goldhaber, S.Z; Goto, S; Haas, S; Misselwitz, F; Turpie, A.G.G; Verheugt, F.W.A; Kakkar, A.K Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗